CD8A and liver cancer: Besides, it was shown that the local immune response of HCC patients might be contributed by tumor-infiltrating CD4+CD25+ regulatory T lymphocytes which suppressed the activity and proliferation of antitumor effector CD4+ and CD8+ T cells, thus, making an effort on the metastasis and recurrence rate of liver cancer [64].